Wee1 inhibitors are a promising new cancer treatment, but serious side effects threaten their adoption in the clinic. Now, ...
Publication of first ever head-to-head comparison of gut microbiome changes associated with novel oral preclinical PolC (pol IIIC*) inhibitors to linezolid ...
The study, published in Proceedings of the National Academy of Sciences of the United States of America, deepens ...
The FDA has approved Hibsago (bepirovirsen) as an add-on antisense oligonucleotide therapy to help noncirrhotic adults with chronic hepatitis B achieve functional cure.
Hello, this is Shion from Meditaliano.I am currently an active medical student attending a public medical school (English ...
Morphological, anatomical and DNA analyses identified the cave-dwelling salifid leech Troglobdella guizhouensis in a single ...
PsyPost on MSN
Genes linked to educational attainment are also tied to fewer behavior problems in kids, mainly through cognitive pathways
A recent study indicates that genetic variants associated with higher educational attainment are also linked to lower levels ...
UCLA investigators have developed a new artificial intelligence-based platform that could help scientists identify promising drug combinations to ...
Kiszala, the CEO and co-founder of intoDNA, to explore how a breakthrough in understanding DNA damage and repair could ...
A narrative review identifies aqueous-humor extracellular-vesicle microRNAs as promising but unvalidated candidates for characterizing the local intraocular environment in HSV-1 anterior uveitis.
Wee1 inhibitors are a promising new cancer treatment, but serious side effects threaten their adoption in the clinic. Now, researchers from the MRC ...
NEJM 2026, Phase III ATOMIC Trial. Immune checkpoint inhibitors have done it againš¤¤. On October 8, 2026, the U.S. FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results